Head-to-Head

Kymera Therapeutics, Inc. Common Stock vs. Maze Therapeutics, Inc. Common Stock

KYMR

Kymera Therapeutics, Inc. Common Stock

$134.84 -1.32%

VS MAZE

Maze Therapeutics, Inc. Common Stock

$36.73 +3.61%

Kymera Therapeutics, Inc. Common Stock (KYMR) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

KYMRMAZE
Market Cap $11.67 billion $1.94 billion

KYMR leads on 1 of 1 size & scale factors.

Risk & Sentiment

KYMRMAZE
Short Interest 0.23% 2.19%

KYMR leads on 1 of 1 risk & sentiment factors.

Dig deeper: KYMR overview, KYMR financials, MAZE overview, MAZE financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.